mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.7 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.7 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.8 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.3 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.6 |